114 related articles for article (PubMed ID: 36856143)
1. The Systemic Immune Inflammation Index (SII) Combined with the Creatinine-to-Cystatin C Ratio (Cre/CysC) Predicts Sarcopenia in Patients with Liver Cirrhosis Complicated with Primary Hepatocellular Carcinoma.
Lei S; Zhang Q; Zhang Q; Long L; Xiong Y; Sun S; Yuan H; Luo Y; Chen N; Peng H; Luo X
Nutr Cancer; 2023; 75(4):1116-1122. PubMed ID: 36856143
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
Hou GM; Jiang C; Du JP; Yuan KF
Cancer Med; 2022 Jan; 11(2):317-331. PubMed ID: 34866356
[TBL] [Abstract][Full Text] [Related]
3. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
4. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
Xiong B; Fu B; Wu Y; Gao F; Hou C
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
[TBL] [Abstract][Full Text] [Related]
6. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
7. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
8. Nomogram model for predicting esophsagogastric varices in hepatocellular carcinoma with cirrhosis.
Zhang D; Deng J; Guo X; Zheng Y; Xu X
Eur J Gastroenterol Hepatol; 2023 Mar; 35(3):342-348. PubMed ID: 36708306
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
Lin T; Jiang T; Huang X; Xu P; Liang R; Song Q; Tu X; Zhao Y; Huang L; Yue J; Wu C
Age Ageing; 2024 Jan; 53(1):. PubMed ID: 38251741
[TBL] [Abstract][Full Text] [Related]
11. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.
Ha Y; Kim D; Han S; Chon YE; Lee YB; Kim MN; Lee JH; Park H; Rim KS; Hwang SG
Cancer Res Treat; 2018 Jul; 50(3):843-851. PubMed ID: 28882021
[TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
Hu B; Yang XR; Xu Y; Sun YF; Sun C; Guo W; Zhang X; Wang WM; Qiu SJ; Zhou J; Fan J
Clin Cancer Res; 2014 Dec; 20(23):6212-22. PubMed ID: 25271081
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune inflammation index and peripheral blood carbon dioxide concentration at admission predict poor prognosis in patients with severe traumatic brain injury.
Chen L; Xia S; Zuo Y; Lin Y; Qiu X; Chen Q; Feng T; Xia X; Shao Q; Wang S
Front Immunol; 2022; 13():1034916. PubMed ID: 36700228
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury defined by cystatin C may be superior for predicting the outcomes of liver cirrhosis with acute gastrointestinal bleeding.
Hong C; Zhu Q; Li Y; Tang S; Lin S; Yang Y; Yuan S; Shao L; Wu Y; Liu B; Li B; Meng F; Chen Y; Hong M; Qi X
Ren Fail; 2022 Dec; 44(1):398-406. PubMed ID: 35225149
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Muscle Mass Using Creatinine/Cystatin C Ratio in Japanese Community-Dwelling Older People.
Kusunoki H; Tabara Y; Tsuji S; Wada Y; Tamaki K; Nagai K; Itoh M; Sano K; Amano M; Maeda H; Sugita H; Hasegawa Y; Kishimoto H; Shimomura S; Igase M; Shinmura K
J Am Med Dir Assoc; 2022 May; 23(5):902.e21-902.e31. PubMed ID: 34437868
[TBL] [Abstract][Full Text] [Related]
18. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
[No Abstract] [Full Text] [Related]
19. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
[TBL] [Abstract][Full Text] [Related]
20. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
